Universitäres Centrum für Tumorerkrankungen Mainz (UCT Mainz)
Klinisch orientierter Schwerpunkt / Johannes Gutenberg-Universität Mainz
du Bois, Andreas; Ewald-Riegler, Nina; de Gregorio, Nikolaus et al.
Borderline tumours of the ovary: A cohort study of the Arbeitsgemeinschaft Gynakologische Onkologie AGO Study Group (vol 49, pg 1905, 2013)EUROPEAN JOURNAL OF CANCER. Bd. 65. 2016 S. 192-193
Witzel, I.; Loibl, S.; Laakmann, E. et al.
Brain metastases in breast cancer network Germany (BMBC, GBG 79): First analysis of 548 patients from the multicenter registryCANCER RESEARCH. Bd. 76. 2016
Laakmann, E.; Witzel, I.; Fehm, T. et al.
Brain Metastases in Breast Cancer Network Germany (BMBC, GBG 79): The introduction of the multicenter register and analysis of patient dataONCOLOGY RESEARCH AND TREATMENT. Bd. 39. 2016 S. 50-50
Paul, N. W.
Breaking bad news in pediatrics: Weight of WordsMONATSSCHRIFT KINDERHEILKUNDE. Bd. 164. H. 7. 2016 S. 583-+
Battista, M. J.; Schmidt, M.; Almstedt, K. et al.
C-met is overexpressed in type I ovarian cancer - results of an explorative analysis in a cohort of consecutive ovarian cancer patientsONCOLOGY RESEARCH AND TREATMENT. Bd. 39. 2016 S. 95-95
Etzold, Anna; Galetzka, Danuta; Weis, Eva et al.
CAF-like state in primary skin fibroblasts with constitutional BRCA1 epimutation sheds new light on tumor suppressor deficiency-related changes in healthy tissueEPIGENETICS. Bd. 11. H. 2. 2016 S. 120-131
Abu-Rmeileh, Niveen M. E.; Gianicolo, Emilio Antonio Luca; Bruni, Antonella et al.
Cancer mortality in the West Bank, Occupied Palestinian TerritoryBMC PUBLIC HEALTH. Bd. 16. 2016
Zimmermann, Anca; Zobeley, Christina; Weber, M. M. et al.
Changes in lipid and carbohydrate metabolism under mTOR- and calcineurin-based immunosuppressive regimen in adult patients after liver transplantationEUROPEAN JOURNAL OF INTERNAL MEDICINE. Bd. 29. 2016 S. 104-109
Ferreri, Andres J. M.; Cwynarski, Kate; Pulczynski, Elko et al.
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trialLANCET HAEMATOLOGY. Bd. 3. H. 5. 2016 S. E217-E227
Mahner, S.; Lueck, H. -J.; Grischke, E. -M. et al.
Chemotherapy (CT) +/- pertuzumab (P) for platinum-resistant ovarian cancer (PROC): AGO-OVAR 2.20/ENGOT-ov14/PENELOPE double-blind placebo-controlled randomized phase 3 trialONCOLOGY RESEARCH AND TREATMENT. Bd. 39. 2016 S. 97-97